Cystic fibrosis. Between normality and disability

被引:0
|
作者
Kappler, M. [1 ]
Griese, M. [1 ]
机构
[1] Univ Munich, Kinderklin & Kinderpoliklin, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany
关键词
Cystic fibrosis; Disability; Therapy burden; Quality of life; Interdisciplinary care; QUALITY-OF-LIFE; CHILDREN; DISEASE; CARE;
D O I
10.1007/s00112-009-1943-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The medical progress of recent decades has dramatically changed the course of congenital diseases previously considered as lethal in childhood. Thus, cystic fibrosis is now seen as a chronic disease which, due to its various limitations, is classified as a disability; however, with a varying and progressive course. Due to its improved prognosis, death and mortality are no longer the only focus of the disease, but rather therapy of the direct, medico-somatic and increasingly indirect, further and often complex limitations caused by cystic fibrosis. Patient quality of life, as with many other diseases, has become the focal point. Cystic fibrosis patients in particular face a multitude of therapeutic and disease-related limiting factors which stand between them and normality. Caring for this patient group requires a multidisciplinary approach involving a wide range of specialities.
引用
收藏
页码:121 / +
页数:7
相关论文
共 50 条
  • [1] Predicting work disability in cystic fibrosis.
    Frangolias, DD
    Holloway, CL
    Vedal, S
    Wilcox, PG
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A684 - A684
  • [2] Pharmacogenetics and cystic fibrosis.
    不详
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (02): : 206 - 206
  • [3] The liver in cystic fibrosis.
    Lacaille, F
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (8-9): : 607 - 618
  • [4] Autoantibodies in Cystic Fibrosis.
    Low, T. B.
    Greene, C. M.
    O'Neill, S. J.
    McElvaney, N. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [5] Referral testing for cystic fibrosis.
    Pratt, VM
    Brown, T
    Kam-Morgan, L
    Eisenberg, M
    Heyward, GC
    Anderson, SM
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 251 - 251
  • [6] Modifier genes in cystic fibrosis.
    Belpinati, F
    Malerba, G
    Quinzii, C
    Patuzzo, C
    Bombieri, C
    Castellani, C
    Assael, BM
    Pignatti, PF
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 533 - 533
  • [7] Osteoporosis in adults with cystic fibrosis.
    Merkel, PA
    Herlyn, K
    Lapey, A
    Pizzo, AS
    Chervinsky, KL
    Evans, SR
    Anderson, EJ
    Schoenfeld, DA
    Finkelstein, JS
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S355 - S355
  • [8] Spicy treatment for cystic fibrosis.
    Schub T.
    Lab Animal, 2004, 33 (6) : 8 - 9
  • [9] Insights into the pathogenesis of cystic fibrosis.
    Welsh, MJ
    Smith, JJ
    Travis, SM
    Greenberg, EP
    FASEB JOURNAL, 1997, 11 (09): : A999 - A999
  • [10] Electrogastrography in children with cystic fibrosis.
    Aktay, AN
    Werlin, SL
    Hoeppner, HE
    GASTROENTEROLOGY, 2000, 118 (04) : A1158 - A1159